Drug Type Blood components |
Synonyms Autoplex, Feiba Nf, Feiba Vh |
Action modulators |
Mechanism F10 modulators(Coagulation factor X modulators), factor IX modulators(Coagulation factor IX modulators), factor VII modulators(Coagulation factor VII modulators) + [2] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date United States (21 Dec 1979), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hemophilia A | United States | 21 Dec 1979 | |
Hemophilia A | United States | 21 Dec 1979 | |
Hemophilia B | United States | 21 Dec 1979 | |
Hemophilia B | United States | 21 Dec 1979 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemophilia A | Phase 3 | United States | 01 Jan 2014 | |
Hemophilia A | Phase 3 | Brazil | 01 Jan 2014 | |
Hemophilia B | Phase 3 | United States | 01 Jan 2014 | |
Hemophilia B | Phase 3 | Brazil | 01 Jan 2014 |
Phase 3 | 45 | (Part 1:FEIBA 85 ± 15 U/kg Regular Volume at 2 U/kg/Min Rate) | tiykfycomh(pxrmpexpiw) = kscljwdaqd ceclwjlbsa (olsolrrzia, bkfplkxgsw - cqukkcdvng) View more | - | 09 Feb 2023 | ||
(Part 1:FEIBA 85±15 U/kg 50% Reduced Volume at 2 U/kg/Min Rate) | tiykfycomh(pxrmpexpiw) = powgxbwgrm ceclwjlbsa (olsolrrzia, cpotwrcmfj - zzywzllmtc) View more |